Effect of arsenic on the risk of gestational diabetes mellitus: a systematic review and meta-analysis

BMC Public Health. 2024 Apr 23;24(1):1131. doi: 10.1186/s12889-024-18596-6.

Abstract

Background: Gestational diabetes mellitus (GDM) is a complication of pregnancy associated with numerous adverse outcomes. There may be a potential link between GDM and arsenic (As) exposure, but this hypothesis remains controversial. This meta-analysis summarizes the latest studies evaluating the association between As and GDM.

Methods: A comprehensive search of the PubMed, Embase, and Scopus databases up to September 2023 was performed. The pooled estimates with 95% CIs were presented using forest plots. Estimates were calculated with random effects models, and subgroup and sensitivity analyses were conducted to address heterogeneity.

Results: A total of 13 eligible studies involving 2575 patients with GDM were included in this meta-analysis. The results showed that women exposed to As had a significantly increased risk of GDM (OR 1.47, 95% CI: 1.11 to 1.95, P = 0.007). Subgroup analyses suggested that the heterogeneity might be attributed to the years of publication. In addition, sensitivity analysis confirmed the robust and reliable results.

Conclusions: This analysis suggested that women exposed to As have a greater risk of GDM. However, the significant heterogeneity across studies requires careful interpretation.

Registration: The PROSPERO registration ID is CRD42023461820.

Keywords: Arsenic; GDM; Gestational diabetes; Meta-analysis; Pregnancy.

Publication types

  • Meta-Analysis
  • Systematic Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arsenic* / adverse effects
  • Arsenic* / toxicity
  • Diabetes, Gestational* / epidemiology
  • Female
  • Humans
  • Pregnancy
  • Risk Factors

Substances

  • Arsenic